03 Apr

Swelife and Medtech4Health – Collaborative project grant

SciCross has been awarded a grant from VINNOVA, with support from Medtech4Heath and Swelife, for the development of a novel way to treat ANCA vasculitis (an autoimmune blood vessel disease). The project will be run in collaboration with Toleranzia AB, Lund University’s Kidney Research Lab and Region Skåne. Additional information can be found in this press release (https://www.toleranzia.com/mfn_news/toleranzia-receives-funding-from-vinnova-for-anca-vasculitis-project/).

30 Oct

AI approaches in chronic inflammatory disease

Together with scientist from UCL, we have written a review article covering AI technologies in the field of chronic inflammatory disease. 

Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges. Peng J, Jury EC, Dönnes P, Ciurtin C. Front Pharmacol. 2021 Sep 30;12:720694. doi: 10.3389/fphar.2021.720694. eCollection 2021.

Pubmed

30 Sep

Covid-19 publications

Check out the latest Covid-19 related publications. SciCross main contributions in these projects has been the design of Sars-CoV-2 peptides used to study T-cell responses. 

An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses, PLoS One. 2021 Sep 30;16(9):e0258041, https://pubmed.ncbi.nlm.nih.gov/34591918/

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19, J Intern Med. 2021 Aug 30, https://pubmed.ncbi.nlm.nih.gov/34459525/